Cargando…
The Addition of C‐Reactive Protein and von Willebrand Factor to Model for End‐Stage Liver Disease‐Sodium Improves Prediction of Waitlist Mortality
BACKGROUND AND AIMS: Patients with cirrhosis on the liver transplant (LT) waiting list may die or be removed because of complications of portal hypertension (PH) or infections. von Willebrand factor antigen (vWF‐Ag) and C‐reactive protein (CRP) are simple, broadly available markers of these processe...
Autores principales: | Starlinger, Patrick, Ahn, Joseph C., Mullan, Aidan, Gyoeri, Georg P., Pereyra, David, Alva‐Ruiz, Roberto, Hackl, Hubert, Reiberger, Thomas, Trauner, Michael, Santol, Jonas, Simbrunner, Benedikt, Mandorfer, Mattias, Berlakovich, Gabriela, Kamath, Patrick S., Heimbach, Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518408/ https://www.ncbi.nlm.nih.gov/pubmed/33786862 http://dx.doi.org/10.1002/hep.31838 |
Ejemplares similares
-
The von Willebrand Factor Facilitates Model for End‐Stage Liver Disease–Independent Risk Stratification on the Waiting List for Liver Transplantation
por: Györi, Georg P., et al.
Publicado: (2020) -
Gut-liver axis signaling in portal hypertension
por: Simbrunner, Benedikt, et al.
Publicado: (2019) -
Recent advances in the understanding and management of hepatorenal syndrome
por: Simbrunner, Benedikt, et al.
Publicado: (2021) -
Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome
por: Simbrunner, Benedikt, et al.
Publicado: (2023) -
Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression
por: Jachs, Mathias, et al.
Publicado: (2022)